In the Media
For interviews or more information please contact email@example.com
BCAL Diagnostics Lists on ASX
BCAL Diagnostics lists on ASX after raising $10 million in IPO. Download ASX Announcement.
Aus Biz Article
BCAL Diagnostics has closed off a $4M pre-IPO capital raise to fund clinical trials of its breast cancer blood test. Jayne Shaw BCAL's
Executive Chair interviewed by Aus Biz. View video.
Breast cancer blood test biotech scores fresh funds - Financial Review
Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise led by Citadel Group's Mark McConnell, which will fund clinical trials for a breakthrough low-cost breast cancer detection blood test.
Founded by healthcare industry veteran and former Vision Group executive Jayne Shaw with former NSW health minister Ron Phillips, the funding round comes after more than a decade of blood, sweat and tears, as well as personal investment, which has led to the commencement of a phase-one... read full article.
Year One In Review - The Sydney Knowledge Hub
Amani Batarseh from BCAL Diagnostics talks about why her work is important and how the Sydney Knowledge Hub is helping BCAL achieve their aims. Download article.
Sydney Knowledge Hub
BCAL Diagnostics partners with Sydney Knowledge Hub And Sydney Mass Spectrometry
BCAL Diagnostics Wins "Win The Future" Contest For International Entrepreneurs in Oceania Programme
BCAL Diagnostics Presents at Heads Over Heels Melbourne
BCAL Diagnostics -NSW Government Industry Sectors Announcements
BCAL Diagnostics is a wholly Australian-owned biotechnology company based at the National Innovation Centre at Eveleigh. Since its establishment in 2010, BCAL Diagnostics has been striving to revolutionise early detection and screening for breast cancer for women worldwide...Read article
Interview with La Roche University
Amani Batarseh is a Senior Research Scientist Lipidomics and Mass Spectrometry for BCAL Diagnostics... Read article
BCAL - The Revolutionary Blood Test for Cancer